Do You Know Which Pharmaceutical Product Sites are Tops Among Physicians in 2009?

Manhattan ResearchShire's ADHD treatment Vyvanse® owns the most popular product site among pediatricians, according to pharmaceutical and healthcare market research company Manhattan Research. The finding comes from the recently released ePharma Physician® market research and strategic advisory service, which focuses on the digital resource and communication preferences and behaviors of physicians who interact with pharmaceutical, device, and biotech companies via the Internet and other technologies. In addition to analyzing physician interaction with over three hundred product sites, the study also tracks usage of online journals, specialty sites, corporate sites, interactive detailing, customer service portals, blogs, wikis, and social networks for over twenty specialist segments.

2009 Top Product Sites Among U.S. Physicians
Ranked by number of physician visitors

CategoryTop SiteCompany
PediatriciansVyvanse® (Vyvanse.com)Shire
Allergy/ImmunologyAdvair® (Advair.com)GlaxoSmithKline
Cardiology/Cardiovascular SurgeryCrestor® (Crestor.com)AstraZeneca
DermatologyBotox® (Botox.com)Allergan
Emergency MedicineLevaquin® (Levaquin.com)Ortho-McNeil-Janssen Pharmaceuticals
EndocrinologyJanuvia® (Januvia.com)Merck
GastroenterologyAmitiza® (Amitiza.com)Sucampo, Takeda
Hematology OncologyAvastin® (Avastin.com)Genentech
Infectious Disease/HIV PhysicianIsentress® (Isentress.com)Merck
Medical OncologyAvastin® (Avastin.com)Genentech
NephrologySensipar® (Sensipar.com)Amgen
NeurologyKeppra XR™ (Kepranxr.com)UCB
OB/GYNLoestrin® 24 Fe (Loestrin24.com)Warner Chilcott
OphthalmologyLatisse® (Latisse.com)Allergan
PsychiatryAbilify® (Abilify.com)BMS, Otsuka
Primary Care PhysiciansJanuvia® (Januvia.com)Merck
PulmonologyAdvair® (Advair.com)GlaxoSmithKline
RheumatologyEnbrel® (Enbrel.com)Amgen, Wyeth
SurgeryLovenox® (Lovenox.com)Sanofi-Aventis
UrologyViagra® (Viagra.com)Pfizer
Source: ePharma Physician® v9.0 (2009)

"As use of the Internet for pharmaceutical information becomes a daily routine for the average physician, digging into the sites used for that information becomes critical insight for brand teams and agency partners," said Mark Bard, President of Manhattan Research. "While product sites are only part of the mix today, understanding how these resources are being used within and across specialty segments is intelligence that no brand should be without today."

Physician Marketing Webinar - Tuesday, August 4
Mr. Bard will host a complimentary physician marketing webinar, "ePharma Physician® v9.0: Navigating the Physician Digital Resource Mix", on Tuesday, August 4 at 11am and 3pm EDT

Session 1: Tuesday, August 4, 11:00 - 11:30 AM EDT
Register here: https://www2.gotomeeting.com/register/550629875

Session 2: Tuesday, August 4, 3:00 - 3:30 PM EDT
Register here: https://www2.gotomeeting.com/register/766231642

ePharma Physician®
ePharma Physician® v9.0 was conducted via online survey methodology in Q2 2009 among 1,517 online practicing U.S. physicians. Since 2002, the study has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit. ePharma Physician® gives insight to the physician digital resource and communication mix of over twenty specialist segments, including topics such as:

  • Product and corporate pharmaceutical websites
  • Specialty-specific sites, online journals, newsletters, and online conferences
  • Interactive detailing, live remote rep, customer service portals, and email communication
  • Web 2.0 technologies such as blogs, podcasts, wikis, and online communities

Specialist groups available in ePharma Physician® include Allergy and Immunology, Cardiology/Cardiovascular Surgery, Dermatology, Emergency Medicine, Endocrinology, Family Medicine/General Practice, Gastroenterology, Infectious Disease/HIV physician, Internal Medicine, Nephrology, Neurology, OB/GYN, Oncology - Hematology & Medical, Ophthalmology, Pediatrics, Psychiatry, Pulmonology, Rheumatology, Surgery (General), and Urology.

ePharma Physician® also provides market data market data for 300+ leading pharmaceutical product websites including Abilify, Actonel, Actos, Advair, Ambien CR, Amitiza, Androgel, Aricept, Asmanex, Astelin, Avandia, Avastin, Avelox, Avodart, Boniva, Botox, Byetta, Celebrex, Chantix, Cialis, Cipro, Concerta, Coreg CR, Crestor, Cymbalta, Daytrana, Depo-Provera, Detrol LA, Diovan, Effexor XR, Enbrel, Evista, Flomax, Flonase, Flovent HFA, Forteo, Fosamax/Fosamax Plus D, Gardasil, Geodon, Humira, Imitrex, Invega, Januvia, Lamictal, Latisse, Levaquin, Levitra, Lexapro, Lipitor, Loestrin 24 Fe, Lovaza, Lovenox, Lunesta, Lupron, Lyrica, Mirena, Namenda, Nasacort, Nasonex, Nexium (purplepill.com), NuvaRing, Pegasys, Plavix, Prevacid, Pristiq, ProAir HFA, Protonix, Provigil, Pulmicort, Relpax, Remicade, Requip, Risperdal, Rozerem, Seasonale, Seasonique, Seroquel, Singulair, Spiriva, Strattera, Symbicort, Tamiflu, Tekturna, Topamax/Topamax360, TriLipix, Ultram ER, Valtrex, Veramyst, Vesicare, Viagra, Vytorin, Vyvanse, Wellbutrin XL, Xyzal, Yaz, Zetia, Zithromax, Zoloft, Zyprexa, Zyvox. A complete list of available product sites is available at http://www.manhattanresearch.com/files/PRESS/ePharma_Physician_v9.0_Product_Site_Listing.pdf.

For additional product and subscription information, please visit http://www.manhattanresearch.com/products/Strategic_Advisory/ePP.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm. We conduct annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health™, Cybercitizen Health™ Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis among more than 100 consumer therapeutic segments and 25 physician specialist segments. For information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...